Neurostimulators, commonly used to relieve spine pain, often render full-body MRI scans unsafe. The stimulators could be damaged by the MRI’s magnets. Medtronic’s stimulator contains a programming feature to eliminate MRI hazards.
Medtronic has applied for U.S. clearance, but has not yet received it from the FDA.
More Articles on Supply Chain:
Medical Device Tax Takes $97M in January
Global Nonfusion Spine Market to Grow to $1B by 2017
Amedica Adds Four Executive Management Officers
